World NEWS
Sarepta CEO on what’s next after expanded muscular dystrophy drug approval
Douglas Ingram, Sarepta CEO, joins ‘Fast Money’ to talk FDA approval of Elevidys and its impact on the company’s stock.
Read Next
July 3, 2024
Biden ‘will be out of the race within a couple of weeks’ if polling, performance issues persist: Doug Schoen
July 3, 2024
New Orleans teen may be trafficking victim after she vanished from group trip to museum
July 3, 2024
Prince William, King Charles in Scotland to bestow country’s highest honor on Queen Camilla
July 3, 2024
Multiple letters circulating among House Dems calling on Biden to step aside for 2024: sources
July 3, 2024
New York’s universal mail-in voting law challenged in court
July 3, 2024
Local dengue fever cases confirmed in Florida Keys, spread by mosquito bites
July 3, 2024
Tourist fatally mowed down in armed robbery at California fashion mall, sparking wild police chase
July 3, 2024
How to safely set off fireworks this Fourth of July
July 3, 2024
Lawsuit alleges that law school’s hiring practices are biased against white men
July 3, 2024
Analysis: Will US Soon Lift Restrictions on Ukraine’s Use of Long-Range Weapons?
Related Articles
Check Also
Close - 8 ways to keep someone you know who lives alone protectedSeptember 10, 2023